Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.
Hemasphere. 2023 Aug 30;7(9):e940. doi: 10.1097/HS9.0000000000000940. eCollection 2023 Sep.
Hemasphere. 2023.
PMID: 37663673
Free PMC article.
No abstract available.
Item in Clipboard
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
Zweegman S, Stege CAM, Haukas E, Schjesvold FH, Levin MD, Waage A, Leys RBL, Klein SK, Szatkowski D, Axelsson P, Hieu Do T, Knut-Bojanowska D, van der Spek E, Svirskaite A, Klostergaard A, Salomo M, Blimark C, Ypma PF, Mellqvist UH, Poddighe PJ, Stevens-Kroef M, van de Donk NWCJ, Sonneveld P, Hansson M, van der Holt B, Abildgaard N.
Zweegman S, et al. Among authors: knut bojanowska d.
Haematologica. 2020 Dec 1;105(12):2879-2882. doi: 10.3324/haematol.2019.240374.
Haematologica. 2020.
PMID: 33256392
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Blimark CH, Vangsted AJ, Klausen TW, Gregersen H, Szabo AG, Hermansen E, Wålinder G, Knut-Bojanowska D, Zang C, Turesson I; Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG).
Blimark CH, et al. Among authors: knut bojanowska d.
Eur J Haematol. 2022 Feb;108(2):99-108. doi: 10.1111/ejh.13707. Epub 2021 Sep 23.
Eur J Haematol. 2022.
PMID: 34514635
Item in Clipboard
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden.
Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH.
Moore KLF, et al. Among authors: knut bojanowska d.
Haematologica. 2023 Jun 1;108(6):1640-1651. doi: 10.3324/haematol.2021.280424.
Haematologica. 2023.
PMID: 36300775
Free PMC article.
Item in Clipboard
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study.
Wålinder G, Genell A, Juliusson G, Svensson R, Santamaria AI, Crafoord J, Carlson K, Knut-Bojanowska D, Veskovski L, Lauri B, Lund J, Turesson I, Hansson M, Blimark CH, Nahi H.
Wålinder G, et al. Among authors: knut bojanowska d.
Cancer Rep (Hoboken). 2022 Nov;5(11):e1614. doi: 10.1002/cnr2.1614. Epub 2022 Mar 3.
Cancer Rep (Hoboken). 2022.
PMID: 35243814
Free PMC article.
Item in Clipboard
Cite
Cite